Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)

v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Disaggregation of Revenue [Line Items]        
Total revenue $ 41,420 $ 24,987 $ 74,581 $ 68,471
Royalties        
Disaggregation of Revenue [Line Items]        
Total revenue 7,181 6,626 13,746 26,164
Kyprolis        
Disaggregation of Revenue [Line Items]        
Total revenue 5,481 4,882 9,886 8,715
Evomela        
Disaggregation of Revenue [Line Items]        
Total revenue 1,199 1,144 2,775 2,055
Other        
Disaggregation of Revenue [Line Items]        
Total revenue 501 600 1,085 1,201
Promacta        
Disaggregation of Revenue [Line Items]        
Total revenue 0 0 0 14,193
Captisol        
Disaggregation of Revenue [Line Items]        
Total revenue 24,468 8,549 45,577 17,508
Service Revenue        
Disaggregation of Revenue [Line Items]        
Total revenue 4,582 4,559 7,939 8,442
Contract Revenue        
Disaggregation of Revenue [Line Items]        
Total revenue 5,189 5,253 7,319 16,357
License Fees        
Disaggregation of Revenue [Line Items]        
Total revenue 660 1,990 1,635 2,840
Milestone        
Disaggregation of Revenue [Line Items]        
Total revenue 3,472 2,497 3,806 12,751
Other        
Disaggregation of Revenue [Line Items]        
Total revenue $ 1,057 $ 766 $ 1,878 $ 766